0001179110-13-014567.txt : 20130924
0001179110-13-014567.hdr.sgml : 20130924
20130924201555
ACCESSION NUMBER: 0001179110-13-014567
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20130924
FILED AS OF DATE: 20130924
DATE AS OF CHANGE: 20130924
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Ophthotech Corp.
CENTRAL INDEX KEY: 0001410939
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 5 VAUGHN DRIVE
STREET 2: SUITE 106
CITY: PRINCETON
STATE: NJ
ZIP: 08540
BUSINESS PHONE: 609-945-6050
MAIL ADDRESS:
STREET 1: 5 VAUGHN DRIVE
STREET 2: SUITE 106
CITY: PRINCETON
STATE: NJ
ZIP: 08540
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: HBM Healthcare Investments (Cayman) Ltd.
CENTRAL INDEX KEY: 0001232258
STATE OF INCORPORATION: E9
FISCAL YEAR END: 0331
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36080
FILM NUMBER: 131113232
BUSINESS ADDRESS:
STREET 1: 2454 WEST BAY ROAD, 3RD FLOOR
CITY: GRAND CAYMAN
STATE: E9
ZIP: 00000
BUSINESS PHONE: 1 345 946 8002
MAIL ADDRESS:
STREET 1: P.O BOX 30852
CITY: GRAND CAYMAN
STATE: E9
ZIP: KY1-1204
FORMER NAME:
FORMER CONFORMED NAME: HBM BIOVENTURES CAYMAN LTD
DATE OF NAME CHANGE: 20030512
3
1
edgar.xml
FORM 3 -
X0206
3
2013-09-24
0
0001410939
Ophthotech Corp.
OPHT
0001232258
HBM Healthcare Investments (Cayman) Ltd.
GOVERNORS SQUARE, SUITE #4-212-2
23 LIME TREE BAY AVE., WEST BAY
GRAND CAYMAN
E9
00000
CAYMAN ISLANDS
0
0
1
0
Series A Preferred Stock
Common Stock
2436346
D
Series B Preferred Stock
Common Stock
353107
D
Series C Preferred Stock
Common Stock
204974
D
Series A Warrant (Right to Buy)
0.059
2017-06-18
Common Stock
11864
D
Each share of Series A Preferred Stock will be automatically converted into Common Stock on a 1 for 5.9 reverse split basis upon the closing of the issuer's firm commitment underwritten public offering pursuant to a registration statement on Form S-1 under the Securities Act of 1933, as amended (the "IPO") and has no expiration date.
Each share of Series B Preferred Stock will be automatically converted into Common Stock on a 1 for 5.9 reverse split basis upon the closing of the issuer's IPO and has no expiration date.
Each share of Series C Preferred Stock will be automatically converted into Common Stock on a 1 for 5.9 reverse split basis upon the closing of the issuer's IPO and has no expiration date.
Immediately exercisable.
Represents the shares of common stock issuable upon the exercise of the warrant, including the conversion of shares of Series A Preferred Stock issuable upon the exercise of the warrant.
/s/ Jean-Marc Lesieur, Director
2013-09-24